title: Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
abstract: Treatment for negative symptoms and cognitive deficits, core elements of schizophrenia, remains inadequate. Stimulation of the prefrontal cortex via transcranial magnetic stimulation (TMS) yields only moderate results, possibly due to limited stimulation depth. Deep-TMS enables deeper and wider stimulation than before. This preliminary study is the first to examine deep-TMS as a possible add-on treatment for negative symptoms and cognitive deficits of schizophrenia. The effect of 20 daily deep-TMS sessions (20 Hz, 120% motor threshold) over the prefrontal cortex of 15 patients indicated improvement in cognition and negative symptoms that was maintained at 2-wk post-treatment follow-up.
authors.affiliation: The Emotion-Cognition Research Center, Shalvata Mental Health Care Center, Hod-Hasharon, Israel, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. levkovit@netvision.net.il
authors.forename: Yechiel
authors.initials: Y
authors.lastname: Levkovitz
authors.forename: Liron
authors.initials: L
authors.lastname: Rabany
authors.forename: Eiran Vadim
authors.initials: EV
authors.lastname: Harel
authors.forename: Abraham
authors.initials: A
authors.lastname: Zangen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003072:Cognition Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy / Q000295:instrumentation / Q000379:methods*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D017397:Prefrontal Cortex / Q000502:physiology; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D012565:Schizophrenic Psychology; D050781:Transcranial Magnetic Stimulation / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods* / Q000523:psychology*
chemical_list: D014150:Antipsychotic Agents